News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Paolo D’Amico

Articles by Paolo D’Amico

TPS 99 Phase 3, Randomized, Open-Label TroFuse-010 Study of Sacituzumab Tirumotecan Alone and With Pembrolizumab Versus Treatment of Physician’s Choice Chemotherapy in Patients With HR+/HER2– Unresectable Locally Advanced or Metastatic Breast Cancer

BySara M. Tolaney, MD, MPH,Paolo D’Amico,Liyi Jia,Kim M. Hirshfield,Fatima Cardoso

April 16th 2025

Latest Updated Articles

Trending on CancerNetwork

What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss

Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer

Classifying High-Risk Patients With NDMM

Unraveling the Complexities of Proximal-Type Epithelioid Sarcoma of the Vulva

CRT Does Not Improve RFS/OS, Confers High-Grade Toxicity in Cervical Cancer

© 2025 MJH Life Sciences^®

All rights reserved.